Skip to main content

Table 2 Preoperative characteristics of four patients

From: Intestinal Behçet's and suspected intestinal Behçet’s disease: a report of four surgical cases

Case

Location of disease

Preoperative treatment

Surgical indication

Operation

Postoperative complication

Postoperative treatment

Histopathological findings

1

Ileum

TNFα (Infliximab)/PSL

Perforation

Small bowel resection

None

TNFα (Infliximab)/PSL(dose up)

Multiple ulcers

2–1

Ileum

PSL

Perforation

Small bowel resection, stoma

High-output syndrome

PSL

Multiple ulcers

2–2

Duodenum

None

Perforation

Omentoplasty

None

IL-1β (canakinumab)/PSL

Ulcer

3

Colon

PSL

Bleeding

Proctocolectomy, stoma

Surgical site infection

PSL

Multiple ulcers

4–1

Ileum

None

Abscess

Ileocecal resection

None

PSL

Ulcer

4–2

Anastomotic site

PSL

Perforation, abscess

Resection of anastomotic site, stoma

None

PSL/5-aminosalicylic acid/colchicine

Ulcer

  1. TNFα: anti-TNF alpha antibodies; PSL: prednisolone, IL-1β: anti-interleukin-1 beta antibodies